Skip to main content
. 2023 Mar 17;18(3):e0283290. doi: 10.1371/journal.pone.0283290

Table 1. Characteristics of household contacts ≥15 years of age and of their index participants and households*.

  Index Participant or Household
N = 279
Household Contacts
N = 712
N (%) N (%)
Individual Characteristics
Country (Number of Sites):
    Botswana (1) 10 (4%) 20 (3%)
    Brazil (1) 10 (4%) 17 (2%)
    Haiti (1) 14 (5%) 37 (5%)
    India (2) 58 (21%) 170 (24%)
    Kenya (1) 7 (3%) 12 (2%)
    Peru (2) 51 (18%) 130 (18%)
    South Africa (7) 120 (43%) 301 (42%)
    Thailand (1) 9 (3%) 25 (4%)
Sex:
    Male 163 (58%) 263 (37%)
    Female 116 (42%) 449 (63%)
Age (years):
    median (range) 36 (18, 74) 34 (15, 90)
    IQR (26, 45) (24, 49)
    15–24 62 (22%) 190 (27%)
    25–34 64 (23%) 171 (24%)
    35–49 103 (37%) 175 (25%)
    ≥50 50 (18%) 176 (25%)
Smoking Status:
    Current 62 (22%) 156 (22%)
    Previous 62 (22%) 54 (8%)
    Never 155 (55%) 502 (71%)
HHC Incarcerated Sometime in Past 12 Mos.a
    Yes 20 (3%)
    No 684 (96%)
    Missing     8 (1%)
HHC Used Alcohol Almost Every Day Sometime in Past 12 Mos.a      
    Yes 57 (8%)
    No 647 (91%)
    Missing     8 (1%)
HHC Used Other Substances (Marijuana, Cocaine, etc.) Sometime in Past 12 Mos.a      
    Yes 58 (8%)
    No 651 (91%)
    Missing     3 (<1%)
HIV Status:
    HIV-infected 101 (36%) 59 (8%)
    HIV-uninfected 150 (54%) 515 (73%)
    Unknown 28 (10%) 138 (18%)
History of Previous TB Treatment:
    Yes 147 (53%) 80 (11%)
    No/Unknown 132 (47%) 632 (89%)
Duration of Index Participant Treatment at Enrollment (weeks)
    Median (range) 9 (0, 27) 9 (0, 33)
    IQR (3, 17) (4, 18)
TB Preventive Treatment: NA
    Current 1 (<1%)
    Previous 8 (1%)
    Never 690 (97%)
    Unknown     13 (2%)
Any Signs or Symptoms Consistent with TB for HHC: NA
    Yes 166 (24%)
    No     538 (76%)
Cavitations on Chest X-rayb:
    Yes 79 (28%) 7 (1%)
    No 102 (37%) 658 (93%)
    Unknown 98 (35%) 46 (6%)
Sputum Smear Status (at Diagnosis for Index Participant and Current for HHC)b:
    Positive 131 (47%) 13 (2%)
    Negative 61 (22%) 170 (24%)
    Unknown 87 (31%) 521 (74%)
Confirmation of TB by Phenotypic or Molecular Test:
    Yes 279 (100%) 22 (3%)
    No/Not Done 0 (0%) 690 (97%)
Index Participant Drug Susceptibility Profileb:
    INH Resistant, RIF Resistant 207 (74%)
    INH Unknown, RIF Resistant 59 (21%)
    INH Susceptible, RIF Resistant 12 (4%)
    INH Indeterminate, RIF Resistant 1 (<1%)  
IGRA Result: NA
    Positive 471 (67%)
    Negative 215 (31%)
    Indeterminate/Borderline 4 (1%)
    Unknown     14 (2%)
Household Characteristics
Number of Household Members (including Index Participant)      
    median (range) 5 (2, 22)
    IQR (3, 6)  
Dwelling Type:
    Brick, Cement, or Concrete House 199 (71%)
    Tin Shack, Prefab House, or Container 60 (22%)
Other (Mud, Mud & Stone, Plastic, Sand, Wood, Adobe, Wendy) 18 (6%)
    Unknown 2 (<1%)  
Flooring Material:
    Hardwood; Asphalt or Vinyl Tile; Ceramic Tile; Carpet 118 (42%)
    Planks; Cement; Dirt; Other 159 (57%)
    Unknown 2 (1%)  
Exterior Wall Material:
    Brick, Cinderblock, Stone with Mortar 212 (76%)
    Adobe, Rammed Earth, Sticks/Stones and Mud, Wood, Straw, Tin, Other 65 (23%)
    Unknown 2 (1%)  
Smoking in Household:      
    Yes 96 (34%)
    No 178 (64%)
Relationship of Index Participant to HHC and Exposure Characteristics
Relationship of IP to HHC:
    Spouse 60 (9%)
    Son/Daughter 127 (18%)
    Mother 55 (8%)
    Father 37 (5%)
    Other     425 (60%)
Sleeping Proximity of IP to HHC:
    Same Room, Same Bed 84 (12%)
    Same Room, Different Bed 156 (22%)
    Different Room     464 (66%)
Sleeping Proximity/Evenings per Week with IP:
    Same Room/Any 240 (34%)
    Different Room/6-7 327 (46%)
    Different Room/3-5 48 (7%)
    Different Room/≤2     89 (13%)

Abbreviations and definitions: IP, index participant; HHC, household contact; %, percentage; N, number; IQR, interquartile range (25th and 75th percentiles); range (minimum and maximum); NA, not available; Mos., months; IGRA, interferon-gamma release assay; INH, isoniazid; RIF, rifampin.

Percentages do not always add to 100% due to rounding. Minimum age of index participants was 18 years. HHCs with documented active TB before study entry did not have data collection on incarceration, TB symptoms, or HIV status; they also did not have chest x-ray, specimen collection for IGRA, TB diagnostics, or HIV testing.

a All self reported. Incarceration is defined as having spent a night in jail, prison, youth detention center; alcohol use as period of drinking alcoholic beverages almost every day; and substance use as any use of substances (marijuana, cocaine, etc.). All use a recall period of 12 months.

b For index participants, TB diagnostic data (including chest x-rays, AFB smear results, TB confirmation, and drug susceptibility results) were obtained from routine TB programs performed at the time of TB diagnosis, which occurred before study entry. Test results obtained from routine labs (molecular, phenotypic, or both) are shown. Some programs used Xpert MTB/RIF alone and therefore have only RIF susceptibility results. The majority of index participants did not have susceptibility testing done for any fluoroquinolones or second-line injectable drugs.